EoCene Ltd.

EOCN Nasdaq SEC CIK 1595353
Follow EoCene Ltd. Weekly email: filings, results

Financials

Reported figures only · latest: Q2 2026 USD · US GAAP
EPS, diluted $2.86 −43.5% vs same quarter last year
Net income by quarter
−$3.2M
−$1.1M
−$4.8M
−$1.9M
Q4 24 Q1 25 Q4 25 Q1 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$20M−$15M−$10M−$5M$0$5MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25--
FY24--
FY23--
FY22--
FY21--
FY20$0-
FY19$0-
FY18$2M−$9.9M
FY17$1.1M−$12.3M
FY16$467K−$17M
FY15$0−$10.6M
FY14$0−$9.1M
FY13-−$17.5M
FY12-−$3.1M
FY11--
MarginsShare of revenue
−4000%−3000%−2000%−1000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearNet margin
FY25-
FY24-
FY23-
FY22-
FY21-
FY20-
FY19-
FY18−483.6%
FY17−1133.5%
FY16−3630.2%
FY15-
FY14-
FY13-
FY12-
FY11-
Free cash flowOperating cash flow minus capital expenditure
−$40M−$30M−$20M−$10M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24-
FY23-
FY22−$18.5M
FY21−$32.9M
FY20−$26.3M
FY19−$14.9M
FY18−$9.1M
FY17−$12.1M
FY16−$12.1M
FY15−$8.6M
FY14−$10M
FY13−$2.5M
FY12−$3.1M
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • EoCene Ltd.
  • Healthcare median
−4000%−3000%−2000%−1000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearEoCene Ltd.Healthcare median
FY25-−30.6%
FY24-−47%
FY23-−58%
FY22-−80.4%
FY21-−71.9%
FY20-−62.2%
FY19-−46.3%
FY18−483.6%−49.6%
FY17−1133.5%−45.9%
FY16−3630.2%−36%
FY15-−38.4%
FY14-−35.5%
FY13-−37.1%
FY12-−29.1%
FY11-−27.9%